AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

In conclusion, the combination of scientific research and positive user experiences suggests that ProDentim is a viable ...

For years scientists have puzzled over why the intracellular pathogen Salmonella is able to survive—and thrive—in human and ...

As public awareness of hygiene and infection control grows in a post-pandemic world, Singapore has launched a strategic national standard to strengthen public health and industry accountability in the ...

A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

As per Vantage Market Research, the Global Plasma Therapy Market has steadily grown over the years due to its potential to ...

Gonorrhoea, a sexually transmitted infection (STI) caused by Neisseria gonorrhoeae, remains a major public health threat globally. In 2020, WHO estimated 82·4 million new global gonorrhoea cases among ...

The retrospective observational study reported by Emile Malembi and colleagues in The Lancet1 provides a comprehensive clinical description of mpox cases caused by ongoing outbreaks in the DR Congo, ...